Rhumbline Advisers Coh Bar, Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$1.09 - $1.49 $18,595 - $25,419	-17,060 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.9 - $1.54 $2,169 - $3,711	2,410 Added 16.45%	17,060 $23,000
Q3 2020 Nov 12, 2020	SELL	$0.87 - $2.08 $4,110 - $9,828	-4,725 Reduced 24.39%	14,650 $14,000
Q2 2020 Aug 13, 2020	BUY	$1.08 - $4.0 $20,925 - $77,500	19,375 New	19,375 $30,000
Q2 2019 Aug 14, 2019	SELL	$1.63 - $3.3 $45,477 - $92,070	-27,900 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$2.95 - $4.16 $1,740 - $2,454	-590 Reduced 2.07%	27,900 $91,000
Q4 2018 Jan 31, 2019	BUY	$2.97 - $4.52 $28,393 - $43,211	9,560 Added 50.5%	28,490 $89,000
Q3 2018 Nov 07, 2018	SELL	$4.13 - $6.84 $4,026 - $6,669	-975 Reduced 4.9%	18,930 $82,000
Q2 2018 Aug 06, 2018	BUY	$4.44 - $10.4 $88,378 - $207,012	19,905 New	19,905 $130,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.